Suisse Innovation
in Wound Care

PATHELEN® Chronical Wound Treatment
A new therapy to treat wound infections also with MRSA, MDR, ESBL, and other antibiotic-resistant-bacteria (Superbugs)

PAWT is a unique therapy which cures the most common chronic wound diseases such as diabetic foot ulcer (DFS), pressure ulcer (Dekubitus), and venous ulcers (ulcus cruris).

Through its revolutionary strategy, a local physical adsorption treatment of wound bacteria is used instead of the traditional approach of a systemic antibiotic treatment. PAWT can even successfully  treat  “hard-to heal” wound infections,  which are “protected” by a Biofilm or wounds which are contaminated with antibiotic resistant MRSA and Extended spectrum beta lactamases (ESBL) producing bacteria like Escherichia coli (EHEC; E.coli) and Klebsiella. 

The unique effect of PATHELEN® THERAPY is achieved through various simultaneous complex mechanisms of:

  • Prevention and elimination of the biofilm
  • Sorption of pus and toxins (including large amounts of problematic lipopolysaccharides)
  • Preparation of a physiological wound environment with granulating tissue
Pathelen Hybrid

The first ambulant PAWT facility is planned to open in Switzerland in 2020.

It can be observed that the general condition of a patient improves significantly after the first application of Pathelen® along with a decrease in wound pain. Additionally, the application of the first PATHELEN® Treatment reduces the risk of a sepsis significantly. 

CASE STUDIES

Starting in 2014, the PATHELEN® ANTIBACTERIAL WOUND TREATMENT has been successfully applied to various patients and in different hospitals. Login to our case studies an examples of successful treatments of MRSA infected wounds:

Successful treatments of MRSA infected wounds

You don’t have an account yet? Request one directly: info07@pathelen.com

Case Studie: Z.V. male, 68 y.o.

Diagnosis

  • Type 2 diabetes mellitus
  • diabetic foot syndrome neuroischemic form;
  • wound infection of the left foot after amputation of fingers.

Microflora

  • Staphylococcus aureus
  • Staphylococcus epidermidis
  • Enterococcus faecium

Case relevant history

  • Ischemic heart disease
  • Hypertensive heart disease
  • Heart failure
  • Atrial fibrillation is a permanent form
White blood cells (WBCs): 8,0×109/l Banded neutrophils – 8% On the lateral surface of the left foot was observed infected wound sized 9 х 3 cm
Date Day of treatment White blood cells Banded neutrophils
2015-04-20 1 (before surgery) 14.0×109/L 19%
2015-04-20 1 (after surgery) 12.3×109/L 15%
2015-04-21 2 (start treatment by Pathelen) 11.9.x109/L 15%
2015-04-22 3 10.0×109/L 11%
2015-04-28 4 9.8×109/L 12%
2015-04-24 5 8.0.x109/L 7%
2015-04-25 6 8.0×109/L 6%
2015-04-28 9 7.8×109/L 5%
2015-04-30 11 7.3×109/L 6%
2015-05-02 13 7.5×109/L 5%
2015-05-05 16 7.2×109/L 5%